Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

NRXP/Javitt succeeded where Mondo Biotech failed. NRXP reached agreement with SUNY and obtained license to continue development of Zyesami. How much of their 50% (collaboration with RLFTF) did NRXP agreed to share with SUNY in the event the FDA grants EUA and eventually approval??? What government agencies are involved in the development of ZYESAMI??? In the event ZYESAMI is granted EUA/approval, what will it take to make RLF-100 an equivalent to Zyesami (TM)??? First and foremost, I want NRXP to get EUA from the FDA!

A drug product is deemed to be therapeutically equivalent ("A" rated) only if: a drug company's approved application contains adequate scientific evidence establishing through in vivo and/or in vitro studies the bioequivalence of the product to a selected reference listed drug.

https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-glossary-terms